Cite
HARVARD Citation
Kiyeleko, S. et al. (2022). Targeting non-alcoholic fatty liver disease: Design, X-ray co-crystal structure and synthesis of 'first-in-kind' inhibitors of serine/threonine kinase25. Bioorganic & medicinal chemistry letters. p. . [Online].